Transforming Lives

Through a new class of safe, durable cancer treatments.

Our Team

Our drug development team has a proven record of translating promising discoveries into therapeutics that profoundly change medical practice.
Learn more
Our Science

Our approach uses a new class of compounds called imipridones to selectively target G protein-coupled receptors (GPCRs) that control critical signaling pathways in cancer.
Learn more
Alliances

Rutgers Cancer Institute of N.J., MD Anderson Cancer Center and Mass. General Hospital/Dana Farber Cancer Institute are conducting ONC201 clinical trials.
Learn more

Learn More About ONC201 Clinical Trials

In The News

- MAY 29 2019
BioSpace: ASCO 2019 Preview: Presentations to Keep An Eye On
Oncoceutics, Inc. – Philadelphia-based Oncoceutics, Inc. will showcase data from its ongoing trial assessing ONC201 in adult recurrent H3 K27M-mutant glioma. The oral abstract session presentation, entitled “Single agent ONC201 in adult recurrent H3 K27M-mutant glioma” will describe the clinical experience of ONC201, in adults with recurrent H3 K27M-mutant glioma. ONC201 is an orally active

Read >

- MAY 28 2019
United States Patent and Trademark Office Issues Patents to Oncoceutics
Earlier this month Oncoceutics confirmed that the United States Patent and Trademark Office (USPTO) has issued patent to the company with an expiration date of January 29, 2036. This newly issued patent covers the composition of matter for ONC213, its di-salt formulation, and its use in the treatment of cancer. In addition to the claims related to

Read >

Press Releases

Jun 04 2019
Publication in Journal for ImmunoTherapy of Cancer Demonstrates ONC201 Immunostimulatory Activity

Read >

Events

Jun 04 2019
Lee Schalop, COO of Oncoceutics to present at Jefferies Healthcare Conference on June 7 at 10:00am

Read >
Jun 03 2019
Dr. Josh Allen to present at 6th Annual Brain Tumor Biotech Summit 2019 in New York, June 7th

Read >
Mar 21 2019
Abstracts to be Presented at AACR 2019

Read >
Nov 19 2018
ONC201 Advocacy Meeting at SNO 2018 – New Orleans, November 17, 2018

Read >

1
2
3
›
»